3 reasons I would buy CSL (ASX:CSL) shares today

Here are three reasons that I think investors ought to buy CSL Limited (ASX:CSL) shares today…
The post 3 reasons I would buy CSL (ASX:CSL) shares today appeared first on Motley Fool Australia. –

Doctor with stethoscope in hand and data graph showing upward trend

If you’re looking to make an investment in the Australian share market, then I think CSL Limited (ASX: CSL) shares would be a great option.

Three key reasons that I rate the company highly are listed below:

Australia’s highest quality business?

The first reason to consider buying CSL is its quality. In fact, I would argue that the biotherapeutics giant is Australia’s highest quality business. It is made up of two businesses – CSL Behring and Seqirus. CSL Behring is a global biotechnology leader which offers the broadest range of quality plasma-derived and recombinant therapies in the industry. Whereas Seqirus is one of the world’s leading vaccines developers with a focus on influenza. It is also supporting the efforts to develop and manufacture a COVID-19 vaccine. Combined, I believe these two businesses have positioned CSL perfectly for growth over the long term.

Attractive valuation.

Although the CSL share price has recovered from its lows, it is still trading some distance from its 52-week high. I think this has left its shares trading at an attractive level for a long-term focused investor. And while the pandemic is having a negative impact on its plasma collections, which are a key ingredient to its immunoglobulin products, I’m optimistic that this will be partly offset by increased demand for seasonal flu vaccines because of the pandemic. This could make now an opportune time to pick up shares.

Research and development pipeline.

Did you know that every year CSL invests approximately 10% to 11% of its sales into research and development (R&D) activities? So, with sales revenue in FY 2020 hitting US$8,797 million, the company is now investing almost US$1 billion each year into its R&D. This high level of investment ensures that the company has some of the most talented scientists in the industry working for it. It also means that its R&D pipeline is filled to the brim with therapies and vaccines that have the potential to generate significant revenues in the future.

Foolish Takeaway.

The CSL share price has smashed the market over the last 10 years. Due to the three reasons listed above, I’m confident it will do the same again over the next decade.

In light of this, I would class CSL shares as a strong buy.

These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

Find out the names of our 3 Post COVID Stocks – For FREE!

*Returns as of 6/8/2020

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 3 reasons I would buy CSL (ASX:CSL) shares today appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!